Sirt1 activation by resveratrol is substrate sequence-selective.

Article Details

Citation
Copy to clipboard

Lakshminarasimhan M, Rauh D, Schutkowski M, Steegborn C

Sirt1 activation by resveratrol is substrate sequence-selective.

Aging (Albany NY). 2013 Mar;5(3):151-4. doi: 10.18632/aging.100542.

PubMed ID
23524286 [ View in PubMed
]
Abstract

Sirtuins are protein deacetylases used as therapeutic targets. Pharmacological Sirt1 activation has been questioned since the in vitro activator resveratrol failed to stimulate deacetylation of several physiological substrates. We tested the influence of substrate sequence by analyzing resveratrol effects on Sirt1-dependent deacetylation of 6802 physiological acetylation sites using peptide microarrays. Resveratrol stimulated deacetylation of a small set of sites and inhibited deacetylation of another set, whereas most substrates were hardly affected. Solution assays confirmed these substrate categories, and statistical analysis revealed their sequence features. Our results reveal substrate sequence dependence for Sirt1 modulation and suggest substrates contributing to resveratrol effects.

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
ResveratrolNAD-dependent protein deacetylase sirtuin-1ProteinHumans
Unknown
Not AvailableDetails